Super-high tumor mutational burden predicts complete remission following immunotherapy: from Peto’s paradox to druggable cancer hallmark
Background The somatic mutation theory predicts that cancer risk should scale proportionally with lifetime cell divisions; yet large-bodied and long-lived species exhibit lower-than-expected cancer incidence—a long-standing contradiction termed Peto’s paradox. Resolving this paradox and clarifying h...
Saved in:
| Main Author: | Ming Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/5/e010486.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Super-high tumor mutational burden predicts complete remission following immunotherapy: from Peto’s paradox to druggable cancer hallmark
Published: (2025-06-01) -
Peto’s paradox: 2 problems 2 answers
by: Chika Edward Uzoigwe
Published: (2025-02-01) -
Towards a more robust comparative oncology: a Bayesian reanalysis of Peto’s paradox and discussion of comparative cancer risk studies in vertebrates
by: Antoine M. Dujon, et al.
Published: (2025-07-01) -
On Advocates of Anti-modernist Emancipation: An Interview with Andrea Petö by Jitka Gelnarová
by: Jitka Gelnarová, et al.
Published: (2016-12-01) -
Plasticity of tumor cell immunogenicity: is it druggable?
by: Glenn Dranoff
Published: (2025-04-01)